Chief Scientific Officer · SOPHiA GENETICS SA · Ordinary Shares
Side
SELL
Value
$3,165
Shares
608
Price
$5.21
Executed
Apr 20, 2026
Disclosed
Apr 21, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 20 executedApr 21, 2026 disclosed
SOPH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 9 prior trades recorded in this security
Frequency & clustering+15 / 15
8 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Xu Zhenyu filed this Form 4 reporting a open-market sale of SOPH on Apr 20, 2026. It became public on Apr 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Xu Zhenyucik:0002006362
Issuer
SOPHiA GENETICS SAcik:0001840706
Revision history · 0
No field has changed since this record was first ingested.
